IP Library Granted Patent US 7,056,669
Granted Patent B2
US 7,056,669 · App. 10/241,376 · Granted Jun 6, 2006

AC methods for the detection of nucleic acids

Assignee: Clinical Micro Sensors, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,056,669
App. No.
10/241,376
Granted
Jun 6, 2006
Kind
B2
Abstract

The invention relates to nucleic acids covalently coupled to electrodes via conductive oligomers. More particularly, the invention is directed to the site-selective modification of nucleic acids with electron transfer moieties and electrodes to produce a new class of biomaterials, and to methods of making and using them.

Claims (15)

1. A composition for detecting a target nucleic acid, comprising:

a) a first and second electrode, wherein said first electrode comprises a monolayer comprising a spacer, wherein said spacer is covalently attached to a single stranded nucleic acid; and

b) an AC/DC voltage source electrically connected to said first and second electrodes.

2. A composition according to claim 1 , wherein said spacer comprises an insulator.

3. A composition according to claim 2 , wherein said insulator comprises an alkyl group.

4. A composition according to claim 3 , wherein said alkyl group is linear.

5. A composition according to claim 3 , wherein said alkyl group is branched.

6. A composition according to claim 2 , wherein said insulator comprises ethylene glycol.

7. A composition according to claim 1 , further comprising a second single stranded nucleic acid covalently attached to an electron transfer moiety.

8. A composition according to claim 7 , wherein said electron transfer moiety is a transition metal complex.

9. A composition according to claim 8 , wherein said transition metal complex comprises ferrocene.

10. A composition according to claim 1 wherein said spacer is a conductive oligomer.

11. A composition according to claim 1 , wherein said monolayer comprises conductive oligomers.

12. A composition according to claim 1 , further comprising c) a processor coupled to said electrodes.

13. A composition according to claim 1 , wherein said AC source is capable of delivering frequencies from between about 1 Hz to about 100 kHz.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: GENMARK DIAGNOSTICS, INC.
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 058189/0563 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2015
From: SQUARE 1 BANK
To: CLINICAL MICRO SENSORS, INC.
Reel/Frame 034729/0052 →
SECURITY INTEREST Recorded Apr 1, 2010
From: OSMETECH TECHNOLOGY INC.
To: SQUARE 1 BANK
Reel/Frame 024312/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2008
From: CLINICAL MICRO SENSORS INC. (DBA OSMETECH MOLECULAR DIAGNOSTICS)
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 021924/0376 →
Continuity (6)
Continuation 0966037400 · Sep 12, 2000
Continuation 0891158900 · Aug 14, 1997
Continuation 0887359700 · Jun 12, 1997
Continuation 0874379800 · Nov 5, 1996
Provisional Application 6004015500 · Mar 7, 1997
Related Publication 20030148328A1 · Aug 7, 2003